Your browser doesn't support javascript.
loading
Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers.
Climax, John; Newsome, Philip N; Hamza, Moayed; Weissbach, Markus; Coughlan, David; Sattar, Naveed; McGuire, Darren K; Bhatt, Deepak L.
Afiliação
  • Climax J; Afimmune Dublin Ireland.
  • Newsome PN; National Institute for Health Research Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham United Kingdom.
  • Hamza M; Centre for Liver and Gastrointestinal Research Institute of Immunology and Immunotherapy University of Birmingham United Kingdom.
  • Weissbach M; Liver Unit University Hospitals Birmingham NHS Foundation Trust Birmingham United Kingdom.
  • Coughlan D; Afimmune Dublin Ireland.
  • Sattar N; Afimmune Dublin Ireland.
  • McGuire DK; Afimmune Dublin Ireland.
  • Bhatt DL; Institute of Cardiovascular and Medical Sciences University of Glasgow United Kingdom.
J Am Heart Assoc ; 9(16): e016334, 2020 08 18.
Article em En | MEDLINE | ID: mdl-32779505

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Placebos / Ácido Eicosapentaenoico / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Am Heart Assoc Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Placebos / Ácido Eicosapentaenoico / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Am Heart Assoc Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido